Accelerated Approval pathway for our ST-920 gene therapy product candidate for the treatment of Fabry disease.

Presentation

Engineering of Allogeneic Regulatory T Cells Expressing a Chimeric Antigen Receptor (Allo-CAR-Tregs) Using Zinc Finger Nuclease/AAV6-Mediated Editing

Download PDF